
Research & Innovation
A new Bundibugyo virus outbreak in the Democratic Republic of Congo has brought attention back to one of the lesser-known species in the ebolavirus family. The World Health Organization has reiterated that the risk of international spread remains low for the general population. For the scientific...

Research & Innovation
Eco-anxiety first appeared in a systematic report in 2017, when the American Psychological Association and ecoAmerica published “Mental Health and Our Changing Climate.” Since then, the age group most represented in climate-related psychological consultations has remained 16 to 24. It isn’t a...

Research & Innovation
In May 2026, the Italian Medicines Agency (AIFA) approved public reimbursement for long-acting PrEP, the long-acting form of pre-exposure prophylaxis that prevents HIV infection in people who don’t have the virus but are at high risk of exposure. Unlike oral PrEP, which requires a daily pill, the...

Research & Innovation
Omics and multiomics technologies are among the most dynamic fronts in biomedical research today: single cell omics emerged roughly a decade ago, while spatial omics is exploding right now. We spoke with Giovanni Tonon, full professor at Vita-Salute San Raffaele University (UniSR), where he also...

Research & Innovation
Time perception, the set of cognitive skills that govern how we process time (how much time has passed, for instance) and manage it, is already there in early childhood. As we grow, this sense of time sharpens, because the brain circuits dedicated to attention, working memory and emotion mature...

Research & Innovation
Bias in medical AI is a concrete problem: it means algorithms that return systematically wrong answers for some groups of patients more often than others. Understanding where it comes from means taking a step back first, to see exactly what bias is and how it differs from two concepts it often gets...
.jpg)
Research & Innovation
Chronic hepatitis B (HBV) remains one of the world's major public health challenges, and finding a functional cure for the infection is one of the toughest goals in virology today. More than 250 million people live with a chronic infection, at risk of developing cirrhosis, liver failure and...

Research & Innovation
Vitiligo is an autoimmune disease that destroys melanocytes, the cells responsible for skin pigmentation, and affects between 0.5 and 2% of the world’s population. Behind the characteristic depigmented patches lies a complex network of biological mechanisms involving the immune system, genetic...

Research & Innovation
A century of oncology has established one principle above all others: accurate diagnosis determines treatment. Hematologic cancer classification is the infrastructure that makes accurate diagnosis possible. Today, under the same tumour type, pathologists can recognise more than 120 distinct...

Research & Innovation
The aging population is often reduced to numbers: rising life expectancy, falling birth rates, pension sustainability, pressure on health systems. Yet behind the figures sits a question that public budgets and demographic indicators never ask directly: who has a right to the future?
Please fill in the form to be updated on our latest news and events